Immatics
high affinity independent | Immatics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
40 of 75
Related slides by other companies
Immix Biopharma
Investor Presentation
November 2023
potential to disrupt the oncology and immunology categories | Immix Biopharma
SentiBio
SPAC
October 2021
armed car cells exhibit significantly improved killing of cancer cells a in tumor cell day post culture ratio i | SentiBio
Mink Therapeutics
Investor Day
November 2022
car enhances infiltration of tumor specific cells to clear tumor mink | Mink Therapeutics
Matinas BioPharma
Investor Presentation
January 2024
in tumor cell inhibition with formulations rationale and next steps | Matinas BioPharma
Other recent decks by Immatics
See all presentations (2 decks)
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights